Novo Nordisk, the Danish multinational healthcare company behind Ozempic, has released a new consumer campaign inspired by Apple’s 2006 ‘Get A Mac’ campaign featuring Justin Long and John Hodgman.
The healthcare company reunited the comedy duo to create ‘There’s Only One Ozempic’, aimed at repositioning and differentiating the weight loss drug from its competitors.
One of the campaign’s first episodes features a gameshow setting with Justin Long representing Ozempic and John Hodgman being the embodiment of other GLP-1 drugs.
“Humour has a way of opening the door to conversations people might otherwise avoid,” said Long.
Momentum for the weight loss drug has slowed down over the past few years as competition in the GLP-1 market intensifies.
After a few initial years of accelerating popularity and an early lead that helped the drug be widely recognised as the original GLP-1 weight loss drug, Novo Nordisk is focused on setting the flagship drug apart.
Much like brands that have come to define an entire category, the name Ozempic is widely recognised, however that recognition is no longer enough to maintain dominance in an overcrowded market.
In order to catch attention in the crowded market, Novo Nordisk aimed to pursue an unconventional approach to weight loss drug advertising. The Danish company aimed to create a campaign that could challenge prevailing misconceptions and cut through widespread media confusion surrounding the product.
Ed Cinca, Novo Nordisk’s senior vice president of marketing and patient solutions said “With our campaign, we’re cutting through the noise with straightforward education about how Ozempic fits into care. Ozempic is the only FDA-approved GLP-1 that improves blood sugar along with diet and exercise and reduces the risk of major cardiovascular events and worsening kidney disease – key information that can make a real difference when choosing a type 2 diabetes treatment.”
The ‘There’s Only One Ozempic’ Campaign, will focus on the use of social media platforms as its main channel. Novo Nordisk’s move to social media platforms signifies a broader cultural shift in how people consume not just advertising and news but also healthcare information.
